Key result
EV71 infection suppresses the miR-17-92 cluster by upregulating DNMT3B-mediated promoter methylation, and serum levels of miR-17, miR-19a/b, and miR-20a are significantly reduced in patients with severe EV71 infection.
Why the study?
Enterovirus 71 is an increasing public health challenge, and evidence suggests mammalian microRNAs participate in host antiviral defense and EV71 replication and pathogenesis.
EV71 promotes its own replication by epigenetically silencing the host antiviral miR-17-92 cluster via DNMT3B-mediated promoter hypermethylation.
Hypothesis-generating for miR-17-92 modulation in EV71; requires human validation before clinical consideration.
Enterovirus 71 (EV71), the etiological agent of hand-foot-and-mouth disease, has become an increasing public health challenge worldwide. Accumulating evidence suggests that mammalian microRNAs (miRNAs), a class of non-coding RNAs of 18 to 24 nucleotides (nt) with important regulatory roles in cellular processes, participate in host antiviral defense and studies have suggested roles of miRNAs in EV71 replication and pathogenesis. In the current study, we reported that the expression of hsa-miR-17∼92 cluster was significantly downregulated during EV71 infection. Overexpression of hsa-miR-17∼92 inhibited, while inhibition of endogenous hsa-miR-17∼92 facilitated EV71 replication. We identified two sequences located at nt 3024 to 3038 and nt 2838 to 2862 of the EV71 (strain FY0805) genome as potential targets for hsa-miR-17-5p and miR-19a/b, respectively, which were validated by luciferase reporter assays and Western blot. Meanwhile, we identified DNA methylation as a novel mechanism of hsa-miR-17∼92 regulatory roles. The methylation of the miR-17-92 promoter was significantly increased (50%) upon EV71 infection, which appeared to be caused by the increased expression of DNMT3B but not DNMT1 and DNMT3A. Furthermore, we demonstrated that the members of miR-17-92 cluster were decreased in the sera of EV71 infected patients, suggesting the clinical implication and the potential therapeutic application of miR-17-92.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2019) studied Enterovirus 71 (EV71) infection / Hand-foot-and-mouth disease (n=63). EV71 infection vs. Healthy controls and mild EV71 cases was evaluated on Serum levels of mature miR-17-92 cluster members (miR-17, miR-19a/b, and miR-20a). EV71 infection suppresses the miR-17-92 cluster by upregulating DNMT3B-mediated promoter methylation, and serum levels of miR-17, miR-19a/b, and miR-20a are significantly reduced in patients with severe EV71 infection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: